Physostigmine reversal of scopolamine delirium in obstetric patients.
D000647:Amnesia / Q000139:chemically induced; D000765:Anesthesia, Conduction / Q000009:adverse effects; D000773:Anesthesia, Obstetrical / Q000009:adverse effects; D001034:Apgar Score; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006339:Heart Rate; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D007744:Obstetric Labor Complications / Q000139:chemically induced* / Q000188:drug therapy; D010146:Pain / Q000517:prevention & control; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects*
D010830:Physostigmine; D012601:Scopolamine